Angiogenesis and tumour proliferation in hepatocellular carcinoma after trans-arterial therapy - Trial SLCTR_2016_023
Access comprehensive clinical trial information for SLCTR_2016_023 through Pure Global AI's free database. This Phase 3 trial is sponsored by Department of Surgery, Faculty of Medicine, University of Kelaniya and is currently status unknown. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2016_023
Phase 3
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2016_023
Angiogenesis and tumour proliferation in hepatocellular carcinoma after trans-arterial therapy
Effect of trans-arterial chemo embolization therapy on angiogenesis and tumour proliferation in patients with hepatocellular carcinoma
Study Focus
Interventional
Sponsor & Location
Department of Surgery, Faculty of Medicine, University of Kelaniya
Sri Lanka
Timeline & Enrollment
Phase 3
N/A
N/A
ICD-10 Classifications
Malignant neoplasm: Hepatoblastoma
Malignant neoplasm: Liver cell carcinoma
Malignant neoplasm: Other specified carcinomas of liver
Malignant neoplasm: Liver, unspecified
Malignant neoplasm: Hepatic flexure
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2016_023
Non-Device Trial